Hepatitis Screening
Roche Molecular initiates trials of Cobas AmpliScreen HBV test
Published in Hepatitis Weekly, September 16th, 2002
The trials mark an important milestone because, for the first time in the U.S., Roche's PCR nucleic acid amplification technology (NAT) test will be evaluated for its safety and effectiveness in screening blood donations for the hepatitis B virus (HBV). In the process, researchers expect to gain a clearer understanding of the prevalence of HBV.
"The clinical trials of the AmpliScreen test will help us learn more about HBV by identifying cases earlier in the course of infection," said Paul V. Holland, MD, chief executive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-09-16)
More Articles from Hepatitis Weekly
- Hemophilia
Hepatitis worse during immunocompetence with HIV/hepatitis C coinfection - Hepatitis C Therapy
Study profiles those likely to discontinue therapy for chronic hepatitis C - Hepatocellular Carcinoma
Growing hepatitis C infection rate associated with primary liver cancer - Liver Transplantation
Genes differentiate acute cellular rejection and hepatitis C recurrence - Finance
Second quarter 2002 revenue increased 164% - Hematopoiesis
Preemptive lamivudine inhibits hepatitis B effects after transplantation - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
